Aimei Health Technology Co., Ltd

Financial Services

NASDAQ:AFJK · NASDAQ Global Market

Market Cap $192.96M Beta 0.23 P/E (TTM) 126.1
$33.01 -4.10%

-$1.41 today

52W Low $6.75High $130.37

Vol 0.00M · Avg 0.02M

EPS (TTM)$0.26
Shell Companies

Management

Put operating results in leadership context

Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.

Return Metrics

ROE, ROIC & ROA over time

Management

ROE

13.2%

avg 5.7%

ROIC

-7.8%

avg -3.1%

ROA

8.8%

avg 4.2%

Analysis

ROE is currently the strongest return metric at 13.2% versus its period average of 5.7%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Management

Key executives, compensation & ownership

Management
NameTitleCompensationTenureAgeShares OwnedOwnership %

Junheng Xie

Chief Executive Officer, Secretary & Director37

Heung Ming Wong

Chief Financial Officer & Director56

Insider Trading

SEC Form 4 transactions — last 12 months

Management

No insider transactions in the last 12 months.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A
RevenueN/AN/AN/A
N/A
Net IncomeN/AN/AN/A
N/A
EBITN/AN/AN/A
N/A

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Who manages AFJK?

Aimei Health Technology Co., Ltd (AFJK) lists 2 active executives. The top listed executive is Junheng Xie, Chief Executive Officer, Secretary & Director.

Are AFJK insiders buying or selling?

Recent insider activity shows net selling of $1.63M.

Explore More

Continue the stock analysis

Jump to another research area for this company.